Samsung Electronics stock analysis for 2030 with HBM, memory-cycle, valuation, and scenario-driven investor guidance.

Amazon long-term outlook with current valuation, Street EPS estimates, AWS and AI data, and disciplined 2030 scenario ranges.

Amazon 2035 bull, base, and bear cases built from current valuation, earnings forecasts, AWS and AI data, and explicit scenario assumptions.

Sony trades at $22.31 as of May 15, 2026. Over the last 10 years the ADR ranged from $5.55 to $29.35, so the stock has already proven it can compound, but it is now much closer to the upper end of ...

Sony trades at $22.31 as of May 15, 2026. Over the last 10 years the ADR ranged from $5.55 to $29.35, so the stock has already proven it can compound, but it is now much closer to the upper end of ...

How AI enters the valuation debate for Siemens. The base case is straightforward: Siemens still has enough operating evidence to justify a constructive sta ...

Eli Lilly's 2035 upside is real, but so is valuation risk. The company has the pipeline and commercial momentum to stay a ...

Base case: AstraZeneca can still compound into 2035, but the distribution of outcomes is much wider than the market often admits. The most defensible range is $265 to $350, because the stock has to ...

Why the current setup can still slip lower. AXA does not screen as a broken company. The bearish case is more subtle: a good insurer can still deliver weak ...

AstraZeneca still deserves a constructive long-term rating, but the next five years are unlikely to repeat the last decade's 15.2% annualized share-price run. A disciplined 2030 base case is $220 to ...

Eli Lilly's base case into 2027 remains constructive because fundamentals are still outrunning the macro backdrop, but the stock already embeds a lot of success. At $1,006.70 on May 14, 2026 and ...

How AI enters the valuation debate for Eli Lilly. Eli Lilly closed at $1,006.70 on May 14, 2026. Over the last 10 years, adjusted monthly closes ranged fro ...